What You Should Know:
- Glooko, a Palo Alto, CA-based provider of remote patient monitoring and chronic care management solutions including diabetes and obesity, today announced that they have raised a $30 million Series D round of funding. The funding was led by Health Catalyst Capital along with participation from existing investors Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic.
- Glooko plans to use these proceeds from this funding to accelerate organic growth and
Read More
Partners
Unite Us Nabs $150M, Reaching $1.6B Valuation to Address Social Determinants of Health
What You Should Know:
- Unite Us, the tech company creating coordinated care networks nationwide, has just announced a $150M Series C round of funding led by ICONIQ Capital, bringing its valuation at $1.65 billion.
- Unite Us is leading the care transformation movement towards whole-person health with its core product, Unite Us Platform, an outcome-focused coordination software sconnecting community-based organizations with health care providers, health plans,
Read More
AI-Powered COVID-19 Solution Reduces Report Turnaround Times by 30%, Study Finds
What You Should Know:
- The Moscow Center for Diagnostics & Telemedicine found that the introduction of RADLogics’ AI-Powered solution into radiology workflow to analyze Chest-CT scans during the COVID-19 pandemic reduced report turnaround time by an average of 30 percent, which is equivalent to 7 minutes per case.
- The study was conducted over two separate phases with the first taking place between April 30, 2020 to June 18, 2020 and the second taking place between June 18, 2020 to
Read More
Variantyx Lands $20M for Whole Genome Sequencing Methodology
What You Should Know:
- Variantyx, a Boston-based provider of high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango
Read More
Reperio Health Raises $6M to Expand At-Home Wellness Kits to Employer Market
What You Should Know:
- Portland, Oregon-based Reperio Health announced it has raised $6M in seed funding co-led by Caduceus Capital Partners in Nashville, Tenn., and Rogue Venture Partnersin Portland, Ore., with additional investment from Liquid 2 Ventures and G Ventures, both out of the San Francisco Bay Area.
- Reperio’s patent-pending at-home health assessment brings a broad range of screenings right to peoples’ doors.
Read More
BioIntelliSense Partners with Leukemia & Lymphoma Society for Continuous Monitoring in Clinical Trials
What You Should Know:
-BioIntelliSense announced it has entered into a strategic partnership with The Leukemia & Lymphoma Society (LLS) to incorporate the BioSticker™ platform in clinical trials of hematological cancer patients.
- The LLS clinical trials will include use of the BioSticker medical device for the continuous collection of vital sign and physiological data which includes temperature, heart rate, respiratory rate at rest, activity level and body position. The BioSticker
Read More
Philips, Disney Partner to Improve Pediatric Experience During MRI Exams
What You Should Know:
- Philips and Walt Disney Company, today announced a partnership partners to conduct first of its kind clinical research pilot program that aims to help reduce fear and anxiety to improve children’s patient experience during MRI exams
- As part of the partnership, Philips will investigate how Philips Ambient Experience – using a series of animated stories, including some of Disney’s most beloved characters, can improve the patient and clinician experience during
Read More
City of Milwaukee Taps NowPow to Improve Health Equity & Outcomes
What You Should Know:
- IMPACT, a designated provider of 211 information and referral services in Southeastern Wisconsin, today announced a groundbreaking collaboration with local health systems, community organizations and NowPow to power one of the nation’s most comprehensive, community-wide systems to connect health and social care and track outcomes.
- As part of the partnership, IMPACT Connect will establish a shared digital platform for partner organizations across multiple sectors —
Read More
DispatchHealth Reaches $1.7B Valuation, Raises $200M for In-Home Care Model
What You Should Know:
- DispatchHealth has secured an additional $200 million in a Series D round of funding led by Tiger Global. The additional financing brings DispatchHealth into the “unicorn” category and solidifies its valuation at more than $1.7 billion.
- DispatchHealth’s new round of financing will allow the company to bring it’s model of in-home medical care to more than 100 markets across the country
Read More
Biden Announces Deal With Merck, Johnson & Johnson to Boost COVID-19 Vaccine Production
What You Should Know:
- President Biden’s administration today announced a historic manufacturing deal between Merck and Johnson & Johnson (J&J), to expand production of J&J’s COVID-19 vaccine. The collaboration will increase manufacture of vaccine drug substance, as well as its fill-finish capacity – two of the biggest bottlenecks facing J&J in the production of its vaccine.
- In addition, the U.S. Department of Health and Human Services (HHS) will collaborate with Merck
Read More
